Daniel Compagno

1.4k total citations
33 papers, 1.1k citations indexed

About

Daniel Compagno is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Daniel Compagno has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Immunology and 10 papers in Oncology. Recurrent topics in Daniel Compagno's work include Galectins and Cancer Biology (19 papers), Signaling Pathways in Disease (11 papers) and Glycosylation and Glycoproteins Research (9 papers). Daniel Compagno is often cited by papers focused on Galectins and Cancer Biology (19 papers), Signaling Pathways in Disease (11 papers) and Glycosylation and Glycoproteins Research (9 papers). Daniel Compagno collaborates with scholars based in Argentina, France and United Kingdom. Daniel Compagno's co-authors include Diego J. Laderach, Lucas D. Gentilini, Gabriel A. Rabinovich, María T. Elola, María F. Troncoso, Anne Galy, Carlota Wolfenstein‐Todel, William Vainchenker, Diego O. Croci and Anne Chauchereau and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daniel Compagno

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Compagno Argentina 20 755 695 230 99 81 33 1.1k
Guorong Luo China 15 860 1.1× 812 1.2× 315 1.4× 52 0.5× 43 0.5× 27 1.4k
Frédéric van den Brûle Belgium 12 628 0.8× 784 1.1× 415 1.8× 212 2.1× 64 0.8× 15 1.3k
Hugues J. M. Nicolay Italy 10 386 0.5× 637 0.9× 289 1.3× 99 1.0× 65 0.8× 14 917
Gabrielle M. Siegers Canada 20 554 0.7× 330 0.5× 409 1.8× 91 0.9× 36 0.4× 41 1.0k
Gemma Texidó Italy 16 359 0.5× 382 0.5× 144 0.6× 65 0.7× 84 1.0× 21 876
Anne Y. Lai United States 15 633 0.8× 755 1.1× 252 1.1× 107 1.1× 98 1.2× 20 1.4k
Akira Yuno United States 16 383 0.5× 459 0.7× 411 1.8× 66 0.7× 71 0.9× 29 844
Sheila Spada United States 11 369 0.5× 370 0.5× 378 1.6× 176 1.8× 92 1.1× 21 835
Melanie Cornejo United States 11 390 0.5× 1.0k 1.5× 381 1.7× 104 1.1× 43 0.5× 19 1.6k
John G. Facciponte United States 17 393 0.5× 407 0.6× 236 1.0× 81 0.8× 38 0.5× 17 718

Countries citing papers authored by Daniel Compagno

Since Specialization
Citations

This map shows the geographic impact of Daniel Compagno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Compagno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Compagno more than expected).

Fields of papers citing papers by Daniel Compagno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Compagno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Compagno. The network helps show where Daniel Compagno may publish in the future.

Co-authorship network of co-authors of Daniel Compagno

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Compagno. A scholar is included among the top collaborators of Daniel Compagno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Compagno. Daniel Compagno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramello, María C., Nicolás Gonzalo Núñez, Jimena Tosello, et al.. (2021). Polyfunctional KLRG-1+CD57+ Senescent CD4+ T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients. Frontiers in Immunology. 12. 713132–713132. 29 indexed citations
2.
Martin, Nicolas, Catherine Gaudin, Frédéric Commo, et al.. (2018). Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer. Clinical Cancer Research. 25(2). 710–723. 15 indexed citations
3.
Compagno, Daniel, et al.. (2018). Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity. Frontiers in Immunology. 9. 2190–2190. 25 indexed citations
4.
Gentilini, Lucas D., Geraldine Gueron, Roberto P. Meiss, et al.. (2017). In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development. Clinical Cancer Research. 23(17). 5135–5148. 24 indexed citations
5.
Gentilini, Lucas D., et al.. (2017). Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer. Oncotarget. 8(27). 44654–44668. 40 indexed citations
6.
Cerliani, Juan P., Tomás Dalotto‐Moreno, Daniel Compagno, et al.. (2014). Study of Galectins in Tumor Immunity: Strategies and Methods. Methods in molecular biology. 1207. 249–268. 6 indexed citations
7.
Salatino, Mariana, Diego O. Croci, Diego J. Laderach, et al.. (2014). Regulation of Galectins by Hypoxia and Their Relevance in Angiogenesis: Strategies and Methods. Methods in molecular biology. 1207. 293–304. 3 indexed citations
8.
Compagno, Daniel, et al.. (2014). Glycans and galectins in prostate cancer biology, angiogenesis and metastasis. Glycobiology. 24(10). 899–906. 46 indexed citations
9.
Ferragut, Fátima, Lucas D. Gentilini, Diego J. Laderach, et al.. (2014). Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors.. PubMed. 29(9). 1093–105. 44 indexed citations
10.
Laderach, Diego J., Lucas D. Gentilini, Diego O. Croci, et al.. (2012). A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease. Cancer Research. 73(1). 86–96. 138 indexed citations
11.
Chauchereau, Anne, Nader Al Nakouzi, Catherine Gaudin, et al.. (2010). Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer. Experimental Cell Research. 317(3). 262–275. 21 indexed citations
12.
Colombo, Lucas L., María F. Troncoso, Marisa M. Fernández, et al.. (2010). Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem‐repeat” lectin galectin‐8. The FASEB Journal. 25(1). 242–254. 118 indexed citations
13.
Laderach, Diego J., Daniel Compagno, Marta A. Toscano, et al.. (2009). Dissecting the signal transduction pathways triggered by galectin–glycan interactions in physiological and pathological settings. IUBMB Life. 62(1). 1–13. 41 indexed citations
14.
Compagno, Daniel, Carole Merle, Aurélie Morin, et al.. (2007). SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas. PLoS ONE. 2(10). e1006–e1006. 48 indexed citations
15.
Olivier, Aurélie, Laurence Jeanson-Leh, Gerben Bouma, et al.. (2005). A Partial Down-regulation of WASP Is Sufficient to Inhibit Podosome Formation in Dendritic Cells. Molecular Therapy. 13(4). 729–737. 39 indexed citations
16.
Rivière, Christel, Peggy Jarrier, Adlen Foudi, et al.. (2005). RGS16 is a negative regulator of SDF-1–CXCR4 signaling in megakaryocytes. Blood. 106(9). 2962–2968. 84 indexed citations
17.
Laderach, Diego J., Daniel Compagno, Olivier Danos, William Vainchenker, & Anne Galy. (2003). RNA Interference Shows Critical Requirement for NF-κB p50 in the Production of IL-12 by Human Dendritic Cells. The Journal of Immunology. 171(4). 1750–1757. 62 indexed citations
18.
Compagno, Daniel & Jean‐Jacques Toulmé. (1999). Antisense Effects of Oligonucleotides Complementary to the Hairpin of theLeishmaniaMini-exon RNA. Nucleosides and Nucleotides. 18(6-7). 1701–1704. 2 indexed citations
19.
Compagno, Daniel, Jed N. Lampe, Chantal Bourget, et al.. (1999). Antisense Oligonucleotides Containing Modified Bases Inhibit in Vitro Translation of Leishmania amazonensis mRNAs by Invading the Mini-exon Hairpin. Journal of Biological Chemistry. 274(12). 8191–8198. 22 indexed citations
20.
Toulmé, Jean‐Jacques, et al.. (1997). Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides. Parasitology. 114(7). 45–59. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guorong Luo Breakdown of academic impact, for papers by Frédéric van den Brûle Breakdown of academic impact, for papers by Hugues J. M. Nicolay Breakdown of academic impact, for papers by Gabrielle M. Siegers Breakdown of academic impact, for papers by Gemma Texidó Breakdown of academic impact, for papers by Anne Y. Lai Breakdown of academic impact, for papers by Akira Yuno Breakdown of academic impact, for papers by Sheila Spada Breakdown of academic impact, for papers by Melanie Cornejo Breakdown of academic impact, for papers by John G. Facciponte
Rankless by CCL
2026